Free Trial

SurgePays (NASDAQ:SURG) Share Price Passes Above 200-Day Moving Average - Time to Sell?

SurgePays logo with Computer and Technology background

Key Points

  • SurgePays shares have recently surpassed their 200-day moving average, which is currently set at $2.27, hitting a high of $3.05 before last trading at $2.94.
  • Analysts have shown a positive outlook, with Ascendiant Capital Markets raising their price target from $8.75 to $9.00 and maintaining a "buy" rating.
  • The company reported better-than-expected earnings with a revenue of $10.58 million for the last quarter, exceeding analysts' projections of $9.80 million.
  • Need better tools to track SurgePays? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

SurgePays, Inc. (NASDAQ:SURG - Get Free Report)'s share price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $2.27 and traded as high as $3.05. SurgePays shares last traded at $2.94, with a volume of 22,889 shares traded.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on SURG shares. Ascendiant Capital Markets upped their price objective on SurgePays from $8.75 to $9.00 and gave the stock a "buy" rating in a research report on Monday, June 16th. Wall Street Zen upgraded SurgePays from a "sell" rating to a "hold" rating in a research report on Thursday, May 22nd.

Get Our Latest Research Report on SURG

SurgePays Stock Down 2.9%

The stock has a market cap of $56.11 million, a PE ratio of -0.98 and a beta of 0.46. The company has a current ratio of 1.72, a quick ratio of 1.41 and a debt-to-equity ratio of 0.24. The business has a 50-day moving average price of $2.98 and a 200-day moving average price of $2.29.

SurgePays (NASDAQ:SURG - Get Free Report) last announced its earnings results on Tuesday, May 13th. The medical equipment provider reported ($0.38) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.40) by $0.02. SurgePays had a negative return on equity of 206.01% and a negative net margin of 136.37%. The firm had revenue of $10.58 million for the quarter, compared to analyst estimates of $9.80 million. During the same quarter last year, the firm posted $0.07 EPS. As a group, analysts forecast that SurgePays, Inc. will post -1.66 earnings per share for the current year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in SURG. D.A. Davidson & CO. purchased a new position in shares of SurgePays during the 1st quarter valued at approximately $25,000. Goldman Sachs Group Inc. purchased a new position in SurgePays in the 1st quarter valued at $28,000. Baader Bank Aktiengesellschaft purchased a new position in SurgePays in the 1st quarter valued at $35,000. XTX Topco Ltd purchased a new position in SurgePays in the 4th quarter valued at $53,000. Finally, Jane Street Group LLC purchased a new position in SurgePays in the 4th quarter valued at $54,000. Hedge funds and other institutional investors own 6.94% of the company's stock.

SurgePays Company Profile

(Get Free Report)

SurgePays, Inc, together with its subsidiaries, operates as a financial technology and telecom company in the United States. It operates through three segments: Mobile Virtual Network Operators, Comprehensive Platform Services, and Lead Generation. The company offers subsidized and non-subsidized mobile virtual network operators for internet connectivity through mobile broadband services to consumers; ACH banking relationships and fintech transactions platform to convenience stores; wireless top-up transactions and wireless product aggregation; and lead generation and case management solutions primarily to law firms in the mass tort industry, as well as call center activities.

Featured Articles

Should You Invest $1,000 in SurgePays Right Now?

Before you consider SurgePays, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SurgePays wasn't on the list.

While SurgePays currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

September Slowdown: 3 Stocks to Buy When the Pullback Comes
3 Overlooked Stocks Riding the AI Data Center Boom
3 Growth Stock Winners to Watch And 3 to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines